Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,9.803252383908614e-76,171.1317269076305,29556.802787804154,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL31', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",3.774252167804816e-73,0,0,77
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.7229165881184957e-50,46.78747708362713,5361.154108345893,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'NDUFV2', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",3.316614432128104e-48,0,0,60
3,Oxidative phosphorylation WP623,1.173112535190481e-31,54.880286540845844,3908.6002061801883,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'NDUFV2', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",1.5054944201611173e-29,0,0,36
4,Nonalcoholic fatty liver disease WP4396,1.6053989960965977e-27,10.589691940938406,653.3461366134621,"['NDUFA13', 'COX7B', 'NDUFA11', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS8', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'CYC1', 'NDUFV2', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'EIF2S1', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",1.5451965337429752e-25,0,0,52
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.9276305353720408e-26,53.053691275167786,3141.3579160111553,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'NDUFV2', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'NDUFAF3', 'TMEM126B']",1.4842755122364715e-24,0,0,30
6,Mitochondrial CIV Assembly WP4922,9.767147240718531e-17,35.0332383665717,1291.4976050187365,"['COX8A', 'COA3', 'COX7B', 'COX16', 'PET100', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14', 'COX20']",6.267252812794391e-15,0,0,20
7,Mitochondrial complex III assembly WP4921,5.464493043846462e-08,31.212406015037594,521.946631455022,"['UQCRB', 'UQCC3', 'UQCRQ', 'LYRM7', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",3.005471174115554e-06,0,0,9
8,Cellular Proteostasis WP4918,4.6925564141895687e-07,inf,inf,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",2.25829277432873e-05,0,0,6
9,mRNA Processing WP411,2.7882227404032167e-05,3.9756723881605622,41.694947988831935,"['SF3B5', 'DHX8', 'NCBP2', 'RNMT', 'SNU13', 'LSM2', 'PRPF4', 'LSM7', 'SNRPD1', 'SNRPG', 'SRSF3', 'SNRPE', 'SNRPB2', 'DNAJC8', 'HNRNPA1', 'SRSF9']",0.001192739727839154,0,0,16
10,Nucleotide Excision Repair WP4753,0.00034310588226829094,5.195018796992481,41.44311420678218,"['POLE4', 'POLD4', 'RFC3', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'GTF2H5', 'RBX1']",0.0132095764673292,0,0,9
11,DNA Mismatch Repair WP531,0.0007560202956695078,7.777647610121837,55.90139370764538,"['POLE4', 'POLD4', 'RFC3', 'POLD2', 'POLE3', 'RPA2']",0.026460710348432774,0,0,6
12,Ciliary landscape WP4352,0.0009538597724864352,2.2449310191366267,15.613481513323011,"['POM121', 'NUDC', 'NDUFA5', 'TRAF3IP1', 'SSNA1', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'PSMD8', 'MYL6', 'COPS6', 'IFT22', 'PSMD7', 'EXOSC4', 'RAB14', 'MFAP1', 'RANBP10', 'NEFL', 'SNRPB2', 'DCAF11', 'CALM2']",0.0306030010339398,0,0,23
13,Translation Factors WP107,0.0010557868650783045,3.848646388627574,26.376578510061083,"['EEF1B2', 'EEF1G', 'EIF2B2', 'EIF1AY', 'EIF3I', 'EIF4H', 'EIF3F', 'EIF2S1', 'EIF3D', 'EIF1']",0.03126753408116517,0,0,10
14,Computational Model of Aerobic Glycolysis WP4629,0.0015651007208422802,8.635299625468164,55.78235254936049,"['LDHA', 'TPI1', 'PGK1', 'ALDOA', 'PFKM']",0.043040269823162704,0,0,5
15,Pyrimidine metabolism WP4022,0.0018785019424526102,3.0432403852784993,19.103274010911207,"['POLE4', 'POLD4', 'POLD2', 'POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'NME1', 'POLR2L']",0.048214883189616996,0,0,12
16,Cholesterol Biosynthesis Pathway WP197,0.0024890485061622373,7.4010165864098445,44.375420584516334,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'PMVK']",0.0563696279336742,0,0,5
17,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.0024890485061622373,7.4010165864098445,44.375420584516334,"['EIF3I', 'EIF3F', 'EIF2S1', 'EIF3D', 'EIF1']",0.0563696279336742,0,0,5
18,VEGFA-VEGFR2 Signaling Pathway WP3888,0.006796037655860289,1.6189479976090855,8.080842184493015,"['RPL5', 'SET', 'ARPC5L', 'TXN', 'RPL10A', 'RPL7', 'ACTG1', 'LDHA', 'RPL18A', 'CCND1', 'TMSB4X', 'RACK1', 'AP2S1', 'PGK1', 'RPLP2', 'ELOC', 'ATP6V1E1', 'RPS11', 'CCT7', 'TMSB10', 'ACP1', 'HRAS', 'PTPN1', 'SDF2L1', 'SSR4', 'RPS6', 'SARS', 'RPL13A', 'TFCP2', 'CYCS', 'RPL27', 'RPL26', 'EIF3F', 'CALR', 'ALDOA', 'EIF3D', 'PTMA']",0.14289228543795718,0,0,37
19,Proteasome Degradation WP183,0.007051827073561522,3.012915352898375,14.927394318661591,"['PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMA2', 'PSME1', 'PSMB10', 'PSMA7']",0.14289228543795718,0,0,9
20,Base Excision Repair WP4752,0.00798350004083896,4.1454545454545455,20.024113937304623,"['POLE4', 'POLD4', 'NEIL2', 'TDG', 'POLD2', 'POLE3']",0.15368237578615,0,0,6
21,Synaptic Vesicle Pathway WP2267,0.009838074265153623,3.073135106937924,14.202479427875591,"['RAB3A', 'SLC32A1', 'AP2S1', 'PARK7', 'SLC25A4', 'AP2M1', 'VAMP2', 'CPLX3']",0.18036469486114975,0,0,8
22,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.01121415056552031,10.345794392523365,46.458605535214936,"['ELOB', 'ELOC', 'RBX1']",0.18771512903153564,0,0,3
23,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.01121415056552031,10.345794392523365,46.458605535214936,"['IDI1', 'HMGCS1', 'PMVK']",0.18771512903153564,0,0,3
24,Amyotrophic lateral sclerosis (ALS) WP2447,0.012756879139918955,3.6570924527261703,15.951083877514472,"['TOMM40', 'BAD', 'NEFL', 'BAX', 'NOS1', 'SOD1']",0.20428671599649617,0,0,6
25,DNA Repair Pathways Full Network WP4946,0.013473262488439818,2.26571844743381,9.758558365523541,"['POLE4', 'POLD4', 'RFC3', 'NEIL2', 'CENPX', 'TDG', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'GTF2H5', 'RBX1']",0.20428671599649617,0,0,12
26,Glycolysis and Gluconeogenesis WP534,0.013795986015347792,2.86067670390157,12.253358507418046,"['LDHA', 'TPI1', 'PDHA1', 'GOT1', 'MPC2', 'PGK1', 'ALDOA', 'PFKM']",0.20428671599649617,0,0,8
27,Photodynamic therapy-induced unfolded protein response WP3613,0.017235187725915424,3.983002016709882,16.1741833000397,"['NARS', 'XBP1', 'DDIT3', 'CALR', 'HSP90B1']",0.24576101016583105,0,0,5
28,Dual hijack model of Vif in HIV infection WP3300,0.0183462339199317,7.758644859813084,31.02162996240046,"['ELOB', 'ELOC', 'RBX1']",0.2522607163990609,0,0,3
29,Mevalonate pathway WP3963,0.02201740468175195,20.676003734827265,78.89801786492191,"['HMGCS1', 'PMVK']",0.29068064801521426,0,0,2
30,Cori Cycle WP1946,0.02265044010508163,4.59993763642033,17.422613377350693,"['LDHA', 'TPI1', 'PGK1', 'ALDOA']",0.29068064801521426,0,0,4
31,Melanoma WP4685,0.032469449352373204,2.368987256874581,8.119598762307167,"['CCND1', 'BAD', 'GADD45A', 'KIT', 'BAX', 'CALM3', 'HRAS', 'CALM2']",0.37186212617874637,0,0,8
32,Selenium Micronutrient Network WP15,0.03259355026343861,2.1164590012863096,7.24599550444659,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'TXN', 'SELENOK', 'SEPHS2', 'SELENOH', 'SOD1', 'MSRB1']",0.37186212617874637,0,0,10
33,Ferroptosis WP4313,0.03265290476183998,2.824657067393712,9.66547217188797,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'VDAC2', 'FTL']",0.37186212617874637,0,0,6
34,Eukaryotic Transcription Initiation WP405,0.03283977218201916,3.235311329588015,11.052195341484143,"['GTF2A2', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.37186212617874637,0,0,5
35,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.03820063265678569,2.7016014017358705,8.820467066543964,"['XBP1', 'MAP1LC3A', 'PPP1R11', 'PPP1R7', 'DDIT3', 'EIF2S1']",0.4202069592246426,0,0,6
36,Gastric acid production WP2596,0.041465942491989885,10.337068160597573,32.90167698333048,"['CCK', 'VIP']",0.44345521831711404,0,0,2
37,Androgen receptor signaling pathway WP138,0.05029016610443006,2.0276847008826415,6.062667204820342,"['CCND1', 'SUMO1', 'BAG1', 'RACK1', 'DSTN', 'STUB1', 'PARK7', 'CALR', 'RAN']",0.5232895662217723,0,0,9
38,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.06511003942800299,6.890756302521009,18.823317239179996,"['COX8A', 'COX5A']",0.6266841294945288,0,0,2
39,Peroxiredoxin 2 induced ovarian failure WP4873,0.06511003942800299,6.890756302521009,18.823317239179996,"['STAR', 'BAX']",0.6266841294945288,0,0,2
40,Trans-sulfuration pathway WP2333,0.06511003942800299,6.890756302521009,18.823317239179996,"['AHCY', 'GOT1']",0.6266841294945288,0,0,2
41,Nanomaterial induced apoptosis WP2507,0.08277475266563636,3.446728971962617,8.587980834638518,"['ENDOG', 'BAX', 'CYCS']",0.7732947469179395,0,0,3
42,NO/cGMP/PKG mediated Neuroprotection WP4008,0.0843594269365025,2.3516768811712634,5.814917855308438,"['BAD', 'NEFL', 'CYCS', 'NOS1', 'CALM2']",0.7732947469179395,0,0,5
43,Mitochondrial CII Assembly WP4920,0.0883415929026801,inf,inf,['SDHAF1'],0.7909654248263218,0,0,1
44,TCA cycle in senescence WP5050,0.09205801549853529,5.167600373482727,12.326464741506106,"['PDHA1', 'GOT1']",0.7982441841658011,0,0,2
45,7q11.23 copy number variation syndrome WP4932,0.09330126827911961,1.7587601078167117,4.171641049660786,"['ATP5PB', 'ATP5MC2', 'EIF4H', 'ATP5PO', 'ATP5MC3', 'ATP5F1D', 'VAMP2', 'ATP5F1E', 'ATP5MC1']",0.7982441841658011,0,0,9
46,DNA Replication WP466,0.09559998202288691,2.2492265103403355,5.28024512477967,"['POLD4', 'RFC3', 'POLD2', 'RPA2', 'UBA52']",0.8001302843219883,0,0,5
47,Non-small cell lung cancer WP4255,0.09796503337541704,1.9069072775748,4.43002147097375,"['EML4', 'CCND1', 'BAD', 'GADD45A', 'CYCS', 'BAX', 'HRAS']",0.8024795287135226,0,0,7
48,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.10081206046215255,3.1017757009345797,7.117015918456118,"['LDHA', 'PDHA1', 'RPS6']",0.8085967349568486,0,0,3
49,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.10755818608216253,2.155313670411985,4.805753135515268,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'PMVK']",0.8367853194818766,0,0,5
50,Alzheimer's disease WP2059,0.10867341811452944,1.7622215562880832,3.91108872258017,"['PSENEN', 'ATP5MD', 'BAD', 'CHP1', 'CYCS', 'CALM3', 'NOS1', 'CALM2']",0.8367853194818766,0,0,8
51,HIF1A and PPARG regulation of glycolysis WP2456,0.12154275247636476,4.133706816059758,8.711742495038306,"['LDHA', 'TPI1']",0.8991477464571476,0,0,2
52,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.12377878068111381,2.298097910820081,4.801322509278464,"['LDHA', 'PDHA1', 'PGK1', 'BAX']",0.8991477464571476,0,0,4
53,Type 2 papillary renal cell carcinoma WP4241,0.12377878068111381,2.298097910820081,4.801322509278464,"['SETD2', 'ELOB', 'ELOC', 'RBX1']",0.8991477464571476,0,0,4
54,Copper homeostasis WP3286,0.1474483654358047,1.9153141905950894,3.666442342071222,"['CCND1', 'SCO2', 'COX17', 'ATOX1', 'SOD1']",0.9999194890104941,0,0,5
55,TP53 network WP1742,0.16267848553830877,2.385334291876348,4.33171819243823,"['SUMO1', 'GADD45A', 'BAX']",0.9999194890104941,0,0,3
56,miRNA Biogenesis WP2338,0.16888568867413936,10.328358208955224,18.36932788623714,['RAN'],0.9999194890104941,0,0,1
57,Myometrial relaxation and contraction pathways WP289,0.17078075954181685,1.4118327478365178,2.495237412837806,"['PKIB', 'GNG3', 'YWHAQ', 'GSTO1', 'CRH', 'CALM3', 'ADCY2', 'IGFBP6', 'NOS1', 'CALM2', 'ACTG1', 'YWHAH']",0.9999194890104941,0,0,12
58,CAMKK2  Pathway WP4874,0.17459638219975487,1.9692636643057597,3.436913251154414,"['FIS1', 'MAP1LC3A', 'NOS1', 'CALM2']",0.9999194890104941,0,0,4
59,Sleep regulation WP3591,0.17459638219975487,1.9692636643057597,3.436913251154414,"['AHCY', 'STAR', 'CRH', 'HCRTR1']",0.9999194890104941,0,0,4
60,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.18402321172224081,1.5741292111917775,2.664518092947678,"['SHC3', 'CCND1', 'RRAS', 'BAD', 'RPS6', 'BAX', 'HRAS']",0.9999194890104941,0,0,7
61,Imatinib and Chronic Myeloid Leukemia WP3640,0.18534618365883312,2.2147530040053405,3.7330324968810014,"['SPRED2', 'GADD45A', 'KIT']",0.9999194890104941,0,0,3
62,Cysteine and methionine catabolism WP4504,0.1855884178806962,2.9521141790049352,4.972021150233323,"['AHCY', 'GOT1']",0.9999194890104941,0,0,2
63,Glycolysis in senescence WP5049,0.1855884178806962,2.9521141790049352,4.972021150233323,"['LDHA', 'PGK1']",0.9999194890104941,0,0,2
64,Homologous recombination WP186,0.1855884178806962,2.9521141790049352,4.972021150233323,"['POLD4', 'POLD2']",0.9999194890104941,0,0,2
65,Unfolded protein response WP4925,0.20876991016780705,2.066915887850467,3.2378703302189598,"['XBP1', 'DDIT3', 'EIF2S1']",0.9999194890104941,0,0,3
66,DNA damage response WP707,0.21744047910678288,1.5510309278350516,2.3666097147829532,"['CCND1', 'GADD45A', 'SESN1', 'RPA2', 'CYCS', 'BAX']",0.9999194890104941,0,0,6
67,ERK Pathway in Huntington's Disease WP3853,0.21911097010828168,2.5828664799253036,3.9212483926616097,"['NTRK2', 'HRAS']",0.9999194890104941,0,0,2
68,Fatty acid transporters WP5061,0.21911097010828168,2.5828664799253036,3.9212483926616097,"['FABP3', 'FABP6']",0.9999194890104941,0,0,2
69,Osteoclast Signaling WP12,0.21911097010828168,2.5828664799253036,3.9212483926616097,"['ATP6V1G1', 'TNFRSF11B']",0.9999194890104941,0,0,2
70,Metabolic reprogramming in colon cancer WP4290,0.23115626822371907,1.7226379794200186,2.5230812019302946,"['LDHA', 'PDHA1', 'PGK1', 'PYCR2']",0.9999194890104941,0,0,4
71,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.23214632079189737,1.513063752943059,2.2096592599411347,"['CCND1', 'BAD', 'GADD45A', 'RAC3', 'CYCS', 'BAX']",0.9999194890104941,0,0,6
72,miRNA regulation of DNA damage response WP1530,0.23214632079189737,1.513063752943059,2.2096592599411347,"['CCND1', 'GADD45A', 'SESN1', 'RPA2', 'CYCS', 'BAX']",0.9999194890104941,0,0,6
73,Canonical and non-canonical Notch signaling WP3845,0.23279671070780855,1.9375584112149533,2.824165168777753,"['RRAS', 'MFAP1', 'DLL3']",0.9999194890104941,0,0,3
74,MED and Pseudoachondroplasia genes WP4789,0.2423198538436814,5.163712686567164,7.319545772568669,['COL9A3'],0.9999194890104941,0,0,1
75,Acute viral myocarditis WP4298,0.24715157144213312,1.4769045387602089,2.064348460152011,"['ENDOG', 'CCND1', 'RAC3', 'CYCS', 'BAX', 'NOS1']",0.9999194890104941,0,0,6
76,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.25093196181425287,1.6535827876520113,2.2861996514244973,"['LATS1', 'YWHAQ', 'ACTG1', 'PAK4']",0.9999194890104941,0,0,4
77,Galanin receptor pathway WP4970,0.25307118674479356,2.29567382508559,3.154449726669831,"['POMC', 'VAMP2']",0.9999194890104941,0,0,2
78,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.25307118674479356,2.29567382508559,3.154449726669831,"['BAD', 'BAX']",0.9999194890104941,0,0,2
79,RalA downstream regulated genes WP2290,0.25307118674479356,2.29567382508559,3.154449726669831,"['RAC3', 'HRAS']",0.9999194890104941,0,0,2
80,Serotonin and anxiety WP3947,0.25307118674479356,2.29567382508559,3.154449726669831,"['POMC', 'CRH']",0.9999194890104941,0,0,2
81,IL-18 signaling pathway WP4754,0.25499749887349094,1.221807922979798,1.669602411037591,"['NRN1', 'TOMM40', 'IMP3', 'BAD', 'COX17', 'TNFRSF11B', 'NDUFC1', 'BPGM', 'RND2', 'PTMS', 'ARL4D', 'NACA', 'TMSB4X', 'CYCS', 'BAX', 'RPS11', 'ITM2C']",0.9999194890104941,0,0,17
82,Gastric Cancer Network 2 WP2363,0.25728083539781416,1.8234194612424408,2.475450639932793,"['RFC3', 'S100A6', 'COL9A3']",0.9999194890104941,0,0,3
83,SARS-CoV-2 mitochondrial interactions WP5038,0.25728083539781416,1.8234194612424408,2.475450639932793,"['NDUFB9', 'IRF3', 'PHB']",0.9999194890104941,0,0,3
84,Proximal tubule transport WP4917,0.2764080115352978,1.4764579989299091,1.8985436808512948,"['ATP6V1G1', 'ATP6V1E1', 'SLC6A20', 'ATP6V1D', 'ATP6V1F']",0.9999194890104941,0,0,5
85,Leptin signaling pathway WP2034,0.2779324264075933,1.4095169123285336,1.804713409621322,"['PTPN1', 'CCND1', 'BAD', 'RPS6', 'BAX', 'HRAS']",0.9999194890104941,0,0,6
86,Glycerophospholipid Biosynthetic Pathway WP2533,0.28713047330263675,2.065919701213819,2.5778929377941098,"['PIP5K1A', 'CDIPT']",0.9999194890104941,0,0,2
87,Nucleotide metabolism WP404,0.28713047330263675,2.065919701213819,2.5778929377941098,"['NME2', 'OAZ1']",0.9999194890104941,0,0,2
88,Endometrial cancer WP4155,0.29403778722454926,1.4353152309612984,1.756893290926348,"['CCND1', 'BAD', 'GADD45A', 'BAX', 'HRAS']",0.9999194890104941,0,0,5
89,BDNF-TrkB Signaling WP3676,0.30708058136813127,1.6311854402361043,1.925851074060082,"['NTRK2', 'HOMER1', 'HRAS']",0.9999194890104941,0,0,3
90,GABA receptor Signaling WP4159,0.30708058136813127,1.6311854402361043,1.925851074060082,"['SLC32A1', 'AP2S1', 'AP2M1']",0.9999194890104941,0,0,3
91,Acetylcholine Synthesis WP528,0.3092711589180623,3.4421641791044775,4.0395065077335115,['PDHA1'],0.9999194890104941,0,0,1
92,Aflatoxin B1 metabolism WP699,0.3092711589180623,3.4421641791044775,4.0395065077335115,['AKR7A3'],0.9999194890104941,0,0,1
93,Cytosine methylation WP3585,0.3092711589180623,3.4421641791044775,4.0395065077335115,['TDG'],0.9999194890104941,0,0,1
94,The alternative pathway of fetal androgen synthesis WP4524,0.3092711589180623,3.4421641791044775,4.0395065077335115,['STAR'],0.9999194890104941,0,0,1
95,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.311849889563119,1.3963963963963963,1.6271276231750138,"['TMSB4X', 'NEFL', 'NOS1', 'PFN2', 'SOD1']",0.9999194890104941,0,0,5
96,Ras signaling WP4223,0.3162699975866022,1.2045789372546507,1.3866618938222688,"['NTRK2', 'GNG10', 'GNG3', 'SHC3', 'RRAS', 'BAD', 'KIT', 'RAC3', 'CALM3', 'CALM2', 'HRAS', 'PAK4']",0.9999194890104941,0,0,12
97,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.32100654502119164,1.8779390544096426,2.133890441553833,"['CD63', 'SOD1']",0.9999194890104941,0,0,2
98,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.32100654502119164,1.8779390544096426,2.133890441553833,"['RRAS', 'HRAS']",0.9999194890104941,0,0,2
99,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.3321492632852389,1.5494859813084112,1.7077982390776818,"['STAR', 'CALM3', 'CALM2']",0.9999194890104941,0,0,3
100,Cytosolic DNA-sensing pathway WP4655,0.33267712723535947,1.424986290764814,1.5683154691648913,"['IRF3', 'POLR3K', 'POLR2K', 'POLR2L']",0.9999194890104941,0,0,4
101,MET in type 1 papillary renal cell carcinoma WP4205,0.33267712723535947,1.424986290764814,1.5683154691648913,"['BAD', 'RPL11', 'HRAS', 'PAK4']",0.9999194890104941,0,0,4
102,Intraflagellar transport proteins binding to dynein WP4532,0.3544661348897923,1.7212885154061626,1.7852214169394274,"['IFT22', 'DYNLL1']",0.9999194890104941,0,0,2
103,Methionine De Novo and Salvage Pathway WP3580,0.3544661348897923,1.7212885154061626,1.7852214169394274,"['AHCY', 'TXN']",0.9999194890104941,0,0,2
104,Bladder cancer WP2828,0.3571821026979619,1.4755674232309746,1.519110732731534,"['CCND1', 'DAPK1', 'HRAS']",0.9999194890104941,0,0,3
105,Effects of nitric oxide WP1995,0.37031142804746403,2.5813899253731343,2.5643809663205457,['NOS1'],0.9999194890104941,0,0,1
106,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.37031142804746403,2.5813899253731343,2.5643809663205457,['MAP1LC3A'],0.9999194890104941,0,0,1
107,Iron metabolism in placenta WP2007,0.37031142804746403,2.5813899253731343,2.5643809663205457,['FTH1'],0.9999194890104941,0,0,1
108,Molybdenum cofactor (Moco) biosynthesis WP4507,0.37031142804746403,2.5813899253731343,2.5643809663205457,['MOCS2'],0.9999194890104941,0,0,1
109,Kit receptor signaling pathway WP304,0.3741815693633074,1.3328102839554603,1.310171328134407,"['BAD', 'RPS6', 'KIT', 'HRAS']",0.9999194890104941,0,0,4
110,Pathways in clear cell renal cell carcinoma WP4018,0.3798608158649339,1.2053001876172609,1.1666707594266834,"['SETD2', 'LDHA', 'TPI1', 'PGBD5', 'PGK1', 'ALDOA', 'PFKM']",0.9999194890104941,0,0,7
111,Blood Clotting Cascade WP272,0.38731854904609764,1.5887380593262945,1.5069304420365497,"['F8A1', 'F11']",0.9999194890104941,0,0,2
112,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.38731854904609764,1.5887380593262945,1.5069304420365497,"['GOT1', 'SCO2']",0.9999194890104941,0,0,2
113,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.38731854904609764,1.5887380593262945,1.5069304420365497,"['LDHA', 'PDHA1']",0.9999194890104941,0,0,2
114,G Protein Signaling Pathways WP35,0.39041165015634227,1.2152819890842934,1.1430378295525268,"['GNG10', 'GNG3', 'RRAS', 'ADCY2', 'HRAS', 'CALM2']",0.9999194890104941,0,0,6
115,p53 transcriptional gene network WP4963,0.41545804491802146,1.2518071264563313,1.0995543881412624,"['SIVA1', 'GADD45A', 'SESN1', 'BAX']",0.9999194890104941,0,0,4
116,Hippo-Yap signaling pathway WP4537,0.4194099763392923,1.4751233826864079,1.2817441091020927,"['LATS1', 'YWHAQ']",0.9999194890104941,0,0,2
117,IL-7 signaling pathway WP205,0.4194099763392923,1.4751233826864079,1.2817441091020927,"['CCND1', 'BAD']",0.9999194890104941,0,0,2
118,Urea cycle and associated pathways WP4595,0.4194099763392923,1.4751233826864079,1.2817441091020927,"['GOT1', 'NOS1']",0.9999194890104941,0,0,2
119,Hippo-Merlin Signaling Dysregulation WP4541,0.4254965481286698,1.1319055887838447,0.9672115638134379,"['LATS1', 'NTRK2', 'CCND1', 'KIT', 'ITGAE', 'HRAS', 'RBX1', 'PAK4']",0.9999194890104941,0,0,8
120,Alanine and aspartate metabolism WP106,0.425962092752429,2.0649253731343284,1.7622174745616332,['GOT1'],0.9999194890104941,0,0,1
121,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.425962092752429,2.0649253731343284,1.7622174745616332,['VIP'],0.9999194890104941,0,0,1
122,Insulin signaling in adipocytes (diabetic condition) WP3635,0.425962092752429,2.0649253731343284,1.7622174745616332,['RPS6'],0.9999194890104941,0,0,1
123,Insulin signaling in adipocytes (normal condition) WP3634,0.425962092752429,2.0649253731343284,1.7622174745616332,['RPS6'],0.9999194890104941,0,0,1
124,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.425962092752429,2.0649253731343284,1.7622174745616332,['AHCY'],0.9999194890104941,0,0,1
125,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.425962092752429,2.0649253731343284,1.7622174745616332,['VEGFB'],0.9999194890104941,0,0,1
126,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.425962092752429,2.0649253731343284,1.7622174745616332,['DLL3'],0.9999194890104941,0,0,1
127,Thiamine metabolic pathways WP4297,0.425962092752429,2.0649253731343284,1.7622174745616332,['PDHA1'],0.9999194890104941,0,0,1
128,Oxidative Damage WP3941,0.4311245889534709,1.2907710280373832,1.0860007386195059,"['BAD', 'GADD45A', 'CYCS']",0.9999194890104941,0,0,3
129,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.4506184699342523,1.376657329598506,1.0973807247022225,"['BAD', 'HRAS']",0.9999194890104941,0,0,2
130,Statin inhibition of cholesterol production WP430,0.4506184699342523,1.376657329598506,1.0973807247022225,"['SQLE', 'APOC1']",0.9999194890104941,0,0,2
131,Pancreatic adenocarcinoma pathway WP4263,0.4551418256835948,1.126488881315498,0.886711446552572,"['CCND1', 'BAD', 'GADD45A', 'RAC3', 'BAX', 'PAK4']",0.9999194890104941,0,0,6
132,Genotoxicity pathway WP4286,0.4560933113199779,1.1800614726713885,0.9264165347743418,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1']",0.9999194890104941,0,0,4
133,Modulators of TCR signaling and T cell activation WP5072,0.4560933113199779,1.1800614726713885,0.9264165347743418,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7']",0.9999194890104941,0,0,4
134,Folate Metabolism WP176,0.4760583362556796,1.1471780480199563,0.8514526139240925,"['AHCY', 'GPX4', 'NOS1', 'SOD1']",0.9999194890104941,0,0,4
135,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.4760583362556796,1.1471780480199563,0.8514526139240925,"['RPS6', 'ADCY2', 'HRAS', 'MYL12B']",0.9999194890104941,0,0,4
136,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.47669862714866146,1.720615671641791,1.2747539034324704,['NSDHL'],0.9999194890104941,0,0,1
137,NO metabolism in cystic fibrosis WP4947,0.47669862714866146,1.720615671641791,1.2747539034324704,['NOS1'],0.9999194890104941,0,0,1
138,NOTCH1 regulation of endothelial cell calcification WP3413,0.47669862714866146,1.720615671641791,1.2747539034324704,['DLL3'],0.9999194890104941,0,0,1
139,Purine metabolism WP4792,0.47669862714866146,1.720615671641791,1.2747539034324704,['APRT'],0.9999194890104941,0,0,1
140,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.47669862714866146,1.720615671641791,1.2747539034324704,['HMGCS1'],0.9999194890104941,0,0,1
141,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.47669862714866146,1.720615671641791,1.2747539034324704,['IDH3B'],0.9999194890104941,0,0,1
142,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.47868101579784866,1.1912652767792955,0.8776299567986103,"['ADCY2', 'BANF1', 'HRAS']",0.9999194890104941,0,0,3
143,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.47868101579784866,1.1912652767792955,0.8776299567986103,"['NTRK2', 'HOMER1', 'HRAS']",0.9999194890104941,0,0,3
144,16p11.2 proximal deletion syndrome WP4949,0.49095451125296546,1.0982946848354451,0.7813310129546974,"['TMEM219', 'ALDOA', 'SEZ6L2', 'CCT7', 'CDIPT']",0.9999194890104941,0,0,5
145,ErbB signaling pathway WP673,0.49095451125296546,1.0982946848354451,0.7813310129546974,"['SHC3', 'CCND1', 'BAD', 'HRAS', 'PAK4']",0.9999194890104941,0,0,5
146,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.4938644902161516,1.0588660166124955,0.7470237387698979,"['NTRK2', 'RAB3A', 'SHC3', 'BAD', 'RPS6', 'RACK1', 'EIF2S1', 'HRAS']",0.9999194890104941,0,0,8
147,Glycosylation and related congenital defects WP4521,0.5100321955316243,1.2144779480419619,0.8176854456297763,"['DPM2', 'DPM3']",0.9999194890104941,0,0,2
148,Circadian rhythm related genes WP3594,0.5109255682019952,1.0322671683913454,0.6931997739079095,"['KDM5A', 'RAI1', 'AHCY', 'HOMER1', 'STAR', 'CAVIN3', 'CRH', 'RPS27A', 'UBA52', 'HCRTR1']",0.9999194890104941,0,0,10
149,Senescence and Autophagy in Cancer WP615,0.5181256771789633,1.0497355169729798,0.6902404109250758,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'MAP1LC3A', 'HRAS', 'GABARAP']",0.9999194890104941,0,0,6
150,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.5229545948508387,1.474680170575693,0.9559771044110077,['SMAD9'],0.9999194890104941,0,0,1
151,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.5229545948508387,1.474680170575693,0.9559771044110077,['CCK'],0.9999194890104941,0,0,1
152,Dopamine metabolism WP2436,0.5229545948508387,1.474680170575693,0.9559771044110077,['SOD1'],0.9999194890104941,0,0,1
153,Macrophage markers WP4146,0.5229545948508387,1.474680170575693,0.9559771044110077,['CD163'],0.9999194890104941,0,0,1
154,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.5229545948508387,1.474680170575693,0.9559771044110077,['IRF3'],0.9999194890104941,0,0,1
155,Serotonin and anxiety-related events WP3944,0.5229545948508387,1.474680170575693,0.9559771044110077,['CRH'],0.9999194890104941,0,0,1
156,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.5229545948508387,1.474680170575693,0.9559771044110077,['PDHA1'],0.9999194890104941,0,0,1
157,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.5381156638513394,1.1469032057267352,0.7107149894541552,"['MAP1LC3A', 'FTL']",0.9999194890104941,0,0,2
158,Oxidative Stress WP408,0.5381156638513394,1.1469032057267352,0.7107149894541552,"['TXN2', 'SOD1']",0.9999194890104941,0,0,2
159,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5381156638513394,1.1469032057267352,0.7107149894541552,"['BAX', 'NOS1']",0.9999194890104941,0,0,2
160,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.5381156638513394,1.1469032057267352,0.7107149894541552,"['TNFRSF11B', 'PPIB']",0.9999194890104941,0,0,2
161,Cell cycle WP179,0.5405402869004219,1.0175461776286234,0.6259802730558874,"['CDKN2D', 'CCND1', 'YWHAQ', 'GADD45A', 'RBX1', 'ANAPC11', 'YWHAH']",0.9999194890104941,0,0,7
162,IL-3 signaling pathway WP286,0.5462499114031257,1.0677408959071866,0.6456401712826871,"['YWHAQ', 'BAD', 'HRAS']",0.9999194890104941,0,0,3
163,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.5527223030846871,1.0320860617399439,0.6119233801345192,"['PSMD8', 'PSMC5', 'PSMD7', 'STUB1']",0.9999194890104941,0,0,4
164,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.5650662552097185,1.0864415941815322,0.6201542130797436,"['RAB3A', 'NEFL']",0.9999194890104941,0,0,2
165,Parkinson's disease pathway WP2371,0.5650662552097185,1.0864415941815322,0.6201542130797436,"['CYCS', 'PARK7']",0.9999194890104941,0,0,2
166,White fat cell differentiation WP4149,0.5650662552097185,1.0864415941815322,0.6201542130797436,"['IRF3', 'DDIT3']",0.9999194890104941,0,0,2
167,Biomarkers for urea cycle disorders WP4583,0.5651253397132706,1.2902285447761195,0.7363434068580635,['GOT1'],0.9999194890104941,0,0,1
168,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.5651253397132706,1.2902285447761195,0.7363434068580635,['CCND1'],0.9999194890104941,0,0,1
169,Major receptors targeted by epinephrine and norepinephrine WP4589,0.5651253397132706,1.2902285447761195,0.7363434068580635,['ADCY2'],0.9999194890104941,0,0,1
170,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5651253397132706,1.2902285447761195,0.7363434068580635,['BAX'],0.9999194890104941,0,0,1
171,Nanoparticle triggered autophagic cell death WP2509,0.5651253397132706,1.2902285447761195,0.7363434068580635,['MAP1LC3A'],0.9999194890104941,0,0,1
172,Nanoparticle triggered regulated necrosis WP2513,0.5651253397132706,1.2902285447761195,0.7363434068580635,['FTL'],0.9999194890104941,0,0,1
173,SARS coronavirus and innate immunity WP4912,0.5651253397132706,1.2902285447761195,0.7363434068580635,['IRF3'],0.9999194890104941,0,0,1
174,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.5676071765552482,1.0320560747663552,0.5844798687555013,"['BEX3', 'SERBP1', 'RNF7']",0.9999194890104941,0,0,3
175,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.5676071765552482,1.0320560747663552,0.5844798687555013,"['RRAS', 'CHP1', 'CALM2']",0.9999194890104941,0,0,3
176,G1 to S cell cycle control WP45,0.5887441074812212,0.9827609247627956,0.5206310069397897,"['CDKN2D', 'CCND1', 'GADD45A', 'RPA2']",0.9999194890104941,0,0,4
177,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.5887441074812212,0.9827609247627956,0.5206310069397897,"['BAD', 'BAX', 'NOS1', 'HRAS']",0.9999194890104941,0,0,4
178,MAPK Cascade WP422,0.5908648044786308,1.0320261437908498,0.5430191784387575,"['RRAS', 'HRAS']",0.9999194890104941,0,0,2
179,Monoamine Transport WP727,0.5908648044786308,1.0320261437908498,0.5430191784387575,"['TNFRSF11B', 'NOS1']",0.9999194890104941,0,0,2
180,Rett syndrome causing genes WP4312,0.5908648044786308,1.0320261437908498,0.5430191784387575,"['EIF2B2', 'GPS2']",0.9999194890104941,0,0,2
181,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.5974095558246153,0.9596680860355934,0.4943752962655486,"['NTRK2', 'YWHAQ', 'TAC1', 'ALDOA', 'SLC25A4', 'VAMP2', 'HSP90B1', 'YWHAH']",0.9999194890104941,0,0,8
182,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.6035713520117139,1.1467661691542288,0.5789919352159312,['STAR'],0.9999194890104941,0,0,1
183,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.6035713520117139,1.1467661691542288,0.5789919352159312,['CCND1'],0.9999194890104941,0,0,1
184,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.6035713520117139,1.1467661691542288,0.5789919352159312,['RRAS'],0.9999194890104941,0,0,1
185,Overview of nanoparticle effects WP3287,0.6035713520117139,1.1467661691542288,0.5789919352159312,['BAX'],0.9999194890104941,0,0,1
186,PPAR-alpha pathway WP2878,0.6035713520117139,1.1467661691542288,0.5789919352159312,['CCND1'],0.9999194890104941,0,0,1
187,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.6035713520117139,1.1467661691542288,0.5789919352159312,['ANAPC11'],0.9999194890104941,0,0,1
188,Serotonin Transporter Activity WP1455,0.6035713520117139,1.1467661691542288,0.5789919352159312,['NOS1'],0.9999194890104941,0,0,1
189,Exercise-induced Circadian Regulation WP410,0.608410800548334,0.9673773364485981,0.48069460283896887,"['IDI1', 'SUMO1', 'STBD1']",0.9999194890104941,0,0,3
190,Notch Signaling Pathway Netpath WP61,0.608410800548334,0.9673773364485981,0.48069460283896887,"['PSENEN', 'CCND1', 'DLL3']",0.9999194890104941,0,0,3
191,Aryl Hydrocarbon Receptor Pathway WP2873,0.6155043609485485,0.9827931172468988,0.4769625200100302,"['AIP', 'BAX']",0.9999194890104941,0,0,2
192,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6155043609485485,0.9827931172468988,0.4769625200100302,"['MAP1LC3A', 'EIF2B2']",0.9999194890104941,0,0,2
193,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6155043609485485,0.9827931172468988,0.4769625200100302,"['CYCS', 'ACTG1']",0.9999194890104941,0,0,2
194,IL-2 signaling pathway WP49,0.6155043609485485,0.9827931172468988,0.4769625200100302,"['RPS6', 'HRAS']",0.9999194890104941,0,0,2
195,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.6155043609485485,0.9827931172468988,0.4769625200100302,"['PTPN1', 'CCND1']",0.9999194890104941,0,0,2
196,Vitamin D-sensitive calcium signaling in depression WP4698,0.6155043609485485,0.9827931172468988,0.4769625200100302,"['GPX4', 'PVALB']",0.9999194890104941,0,0,2
197,Apoptosis Modulation and Signaling WP1772,0.6204563256512461,0.9378035273068075,0.4476136822431196,"['ENDOG', 'AIFM2', 'BAD', 'CYCS', 'BAX', 'TNFRSF11B']",0.9999194890104941,0,0,6
198,Integrated breast cancer pathway WP1984,0.6207726121641964,0.9377451816476207,0.44710792659697374,"['CCND1', 'RRAS', 'GADD45A', 'BAD', 'BAX', 'PHB', 'FAU']",0.9999194890104941,0,0,7
199,22q11.2 copy number variation syndrome WP4657,0.6358041624332403,0.921030631353665,0.41710224560289083,"['RANBP1', 'MRPL40', 'RAN', 'RBX1', 'PAK4']",0.9999194890104941,0,0,5
200,15q13.3 copy number variation syndrome WP4942,0.6386213386768166,1.0319962686567163,0.4627921058888439,['TRPM1'],0.9999194890104941,0,0,1
201,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.6386213386768166,1.0319962686567163,0.4627921058888439,['CCND1'],0.9999194890104941,0,0,1
202,Genes targeted by miRNAs in adipocytes WP1992,0.6386213386768166,1.0319962686567163,0.4627921058888439,['TMSB4X'],0.9999194890104941,0,0,1
203,Hedgehog Signaling Pathway Netpath WP47,0.6386213386768166,1.0319962686567163,0.4627921058888439,['SAP18'],0.9999194890104941,0,0,1
204,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.6386213386768166,1.0319962686567163,0.4627921058888439,['CCND1'],0.9999194890104941,0,0,1
205,Osteoblast Signaling WP322,0.6386213386768166,1.0319962686567163,0.4627921058888439,['TNFRSF11B'],0.9999194890104941,0,0,1
206,Purine metabolism and related disorders WP4224,0.6386213386768166,1.0319962686567163,0.4627921058888439,['APRT'],0.9999194890104941,0,0,1
207,Transcriptional cascade regulating adipogenesis WP4211,0.6386213386768166,1.0319962686567163,0.4627921058888439,['DDIT3'],0.9999194890104941,0,0,1
208,Glycogen Synthesis and Degradation WP500,0.638988183012532,0.9380358203887615,0.42011746286855667,"['CALM3', 'CALM2']",0.9999194890104941,0,0,2
209,Histone Modifications WP2369,0.638988183012532,0.9380358203887615,0.42011746286855667,"['SETD2', 'SET']",0.9999194890104941,0,0,2
210,miRNA regulation of prostate cancer signaling pathways WP3981,0.638988183012532,0.9380358203887615,0.42011746286855667,"['CCND1', 'BAD']",0.9999194890104941,0,0,2
211,p38 MAPK Signaling Pathway WP400,0.638988183012532,0.9380358203887615,0.42011746286855667,"['DDIT3', 'HRAS']",0.9999194890104941,0,0,2
212,PDGF Pathway WP2526,0.638988183012532,0.9380358203887615,0.42011746286855667,"['ARFIP2', 'HRAS']",0.9999194890104941,0,0,2
213,Thermogenesis WP4321,0.639445027800727,0.9169940754599314,0.41003813999243827,"['RPS6', 'ADCY2', 'HRAS', 'ACTG1']",0.9999194890104941,0,0,4
214,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.6465611542620984,0.910307861462342,0.39697387263323713,"['IDI1', 'SQLE', 'HMGCS1']",0.9999194890104941,0,0,3
215,Head and Neck Squamous Cell Carcinoma WP4674,0.6554075761533156,0.8969780778460162,0.3789714288620795,"['CCND1', 'SESN1', 'RPS6', 'HRAS']",0.9999194890104941,0,0,4
216,Endothelin Pathways WP2197,0.6613279917466524,0.8971704623878537,0.3709847921906475,"['RIIAD1', 'CALM2']",0.9999194890104941,0,0,2
217,Complement system WP2806,0.6643297002235328,0.8891095182745706,0.36362509117760045,"['RPS19', 'F11', 'CD59', 'TXN', 'CALR']",0.9999194890104941,0,0,5
218,Apoptosis Modulation by HSP70 WP384,0.6705750230070763,0.9380936227951153,0.3748806840299049,['CYCS'],0.9999194890104941,0,0,1
219,Glutathione metabolism WP100,0.6705750230070763,0.9380936227951153,0.3748806840299049,['GPX4'],0.9999194890104941,0,0,1
220,Glycerolipids and Glycerophospholipids WP4722,0.6705750230070763,0.9380936227951153,0.3748806840299049,['CDIPT'],0.9999194890104941,0,0,1
221,Transcription co-factors SKI and SKIL protein partners WP4533,0.6705750230070763,0.9380936227951153,0.3748806840299049,['LATS1'],0.9999194890104941,0,0,1
222,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.6705750230070763,0.9380936227951153,0.3748806840299049,['CCND1'],0.9999194890104941,0,0,1
223,Integrin-mediated Cell Adhesion WP185,0.6780339186512097,0.8739605154573732,0.3395843191876198,"['SHC3', 'RAC3', 'ITGAE', 'HRAS', 'PAK4']",0.9999194890104941,0,0,5
224,Regulation of Actin Cytoskeleton WP51,0.6813170039544689,0.8801651947101085,0.33774366316997695,"['RRAS', 'TMSB4X', 'PIP5K1A', 'BRK1', 'RAC3', 'ACTG1', 'PAK4']",0.9999194890104941,0,0,7
225,Cardiac Progenitor Differentiation WP2406,0.6825424529732568,0.8597105508870215,0.32834972500162674,"['MESP1', 'KIT']",0.9999194890104941,0,0,2
226,Common Pathways Underlying Drug Addiction WP2636,0.6825424529732568,0.8597105508870215,0.32834972500162674,"['CALM2', 'ACTG1']",0.9999194890104941,0,0,2
227,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.6858827176361512,0.8594480823199252,0.324053723213119,"['POMC', 'BAD', 'RPS6', 'HRAS']",0.9999194890104941,0,0,4
228,Small cell lung cancer WP4658,0.6913595934487644,0.8593164794007491,0.3171695833973629,"['CCND1', 'GADD45A', 'CYCS', 'BAX', 'CKS1B']",0.9999194890104941,0,0,5
229,Pathogenic Escherichia coli infection WP2272,0.6986944555145177,0.8362717858044961,0.29983834862635617,"['YWHAQ', 'ARPC5L', 'ACTG1']",0.9999194890104941,0,0,3
230,Prader-Willi and Angelman Syndrome WP3998,0.6986944555145177,0.8362717858044961,0.29983834862635617,"['POMC', 'CCND1', 'FEZ1']",0.9999194890104941,0,0,3
231,Airway smooth muscle cell contraction WP4962,0.6997056981122398,0.8598414179104478,0.30704546976236213,['CALM2'],0.9999194890104941,0,0,1
232,Kynurenine Pathway and links to Cellular Senescence WP5044,0.6997056981122398,0.8598414179104478,0.30704546976236213,['NOS1'],0.9999194890104941,0,0,1
233,miRNAs involved in DNA damage response WP1545,0.6997056981122398,0.8598414179104478,0.30704546976236213,['CCND1'],0.9999194890104941,0,0,1
234,MTHFR deficiency WP4288,0.6997056981122398,0.8598414179104478,0.30704546976236213,['CYCS'],0.9999194890104941,0,0,1
235,Nicotine Activity on Dopaminergic Neurons WP1602,0.6997056981122398,0.8598414179104478,0.30704546976236213,['ADCY2'],0.9999194890104941,0,0,1
236,Retinoblastoma gene in cancer WP2446,0.7003886896034647,0.8418319619709437,0.29979305281376434,"['RFC3', 'CCND1', 'H2AFZ', 'RPA2']",0.9999194890104941,0,0,4
237,Aryl Hydrocarbon Receptor Netpath WP2586,0.7026558607281176,0.8252474323062559,0.29121994607731383,"['AIP', 'HRAS']",0.9999194890104941,0,0,2
238,Interleukin-11 Signaling Pathway WP2332,0.7026558607281176,0.8252474323062559,0.29121994607731383,"['RPS6', 'HRAS']",0.9999194890104941,0,0,2
239,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.7026558607281176,0.8252474323062559,0.29121994607731383,"['LATS1', 'YWHAQ']",0.9999194890104941,0,0,2
240,TGF-beta Signaling Pathway WP366,0.709204045821966,0.8473379466177093,0.2911554865383286,"['PARD6A', 'CCND1', 'CITED1', 'SUMO1', 'STRAP', 'RBX1']",0.9999194890104941,0,0,6
241,Calcium Regulation in the Cardiac Cell WP536,0.7200753402653618,0.8499878999080392,0.2791355445472188,"['PKIB', 'GNG3', 'YWHAQ', 'CALM3', 'ADCY2', 'CALR', 'CALM2', 'YWHAH']",0.9999194890104941,0,0,8
242,IL-6 signaling pathway WP364,0.7216969990757548,0.7934353228470875,0.25877884885850916,"['BAD', 'VIP']",0.9999194890104941,0,0,2
243,Integrated Cancer Pathway WP1971,0.7216969990757548,0.7934353228470875,0.25877884885850916,"['BAD', 'BAX']",0.9999194890104941,0,0,2
244,Neovascularisation processes WP4331,0.7216969990757548,0.7934353228470875,0.25877884885850916,"['KIT', 'SMAD9']",0.9999194890104941,0,0,2
245,Phosphoinositides metabolism WP4971,0.7216969990757548,0.7934353228470875,0.25877884885850916,"['PIP4P1', 'PIP5K1A']",0.9999194890104941,0,0,2
246,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7262625556173496,0.7936280137772675,0.2538369066044949,['BAX'],0.9999194890104941,0,0,1
247,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.7262625556173496,0.7936280137772675,0.2538369066044949,['HRAS'],0.9999194890104941,0,0,1
248,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.7262625556173496,0.7936280137772675,0.2538369066044949,['IRF3'],0.9999194890104941,0,0,1
249,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7262625556173496,0.7936280137772675,0.2538369066044949,['CALM2'],0.9999194890104941,0,0,1
250,Neural Crest Cell Migration in Cancer WP4565,0.7396981608366299,0.7639796659404503,0.23034985201639252,"['NTRK2', 'PAK4']",0.9999194890104941,0,0,2
251,Prolactin Signaling Pathway WP2037,0.7409802116707025,0.7930488594660718,0.2377412647969286,"['PTPN1', 'RPS6', 'PPIB', 'HRAS']",0.9999194890104941,0,0,4
252,Fatty acid beta-oxidation WP143,0.7504728093973505,0.7368736673773987,0.21152095573612098,['TPI1'],0.9999194890104941,0,0,1
253,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.7504728093973505,0.7368736673773987,0.21152095573612098,['H2AFZ'],0.9999194890104941,0,0,1
254,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.7504728093973505,0.7368736673773987,0.21152095573612098,['RPS6'],0.9999194890104941,0,0,1
255,Physiological and pathological hypertrophy of the heart WP1528,0.7504728093973505,0.7368736673773987,0.21152095573612098,['CALM2'],0.9999194890104941,0,0,1
256,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.756694303919515,0.7366279845271442,0.2053688861008621,"['STAR', 'HRAS']",0.9999194890104941,0,0,2
257,One-carbon metabolism and related pathways WP3940,0.756694303919515,0.7366279845271442,0.2053688861008621,"['GPX4', 'SOD1']",0.9999194890104941,0,0,2
258,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.756694303919515,0.7366279845271442,0.2053688861008621,"['CCND1', 'BAX']",0.9999194890104941,0,0,2
259,Apoptosis WP254,0.7656345876915158,0.7635380937532481,0.20390304846354002,"['IRF3', 'BAD', 'CYCS', 'BAX']",0.9999194890104941,0,0,4
260,Nanoparticle-mediated activation of receptor signaling WP2643,0.7725436321814991,0.6876865671641791,0.1774690649258177,['HRAS'],0.9999194890104941,0,0,1
261,NRF2-ARE regulation WP4357,0.7725436321814991,0.6876865671641791,0.1774690649258177,['RBX1'],0.9999194890104941,0,0,1
262,PDGFR-beta pathway WP3972,0.7725436321814991,0.6876865671641791,0.1774690649258177,['HRAS'],0.9999194890104941,0,0,1
263,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7725436321814991,0.6876865671641791,0.1774690649258177,['BAX'],0.9999194890104941,0,0,1
264,Striated Muscle Contraction Pathway WP383,0.7725436321814991,0.6876865671641791,0.1774690649258177,['ACTG1'],0.9999194890104941,0,0,1
265,PPAR signaling pathway WP3942,0.7727223297916448,0.7111626259699282,0.18336297555989436,"['FABP3', 'FABP6']",0.9999194890104941,0,0,2
266,DNA damage response (only ATM dependent) WP710,0.7739428897018146,0.7690480183352898,0.19707408725269704,"['CCND1', 'BAD', 'RAC3', 'BAX', 'HRAS']",0.9999194890104941,0,0,5
267,TNF-alpha signaling pathway WP231,0.777256366740064,0.7495875499617315,0.1888848477934472,"['BAD', 'BAX', 'TXN', 'HRAS']",0.9999194890104941,0,0,4
268,Breast cancer pathway WP4262,0.7826884155231872,0.7837813035320988,0.19204256443032605,"['SHC3', 'CCND1', 'GADD45A', 'KIT', 'BAX', 'HRAS', 'DLL3']",0.9999194890104941,0,0,7
269,Insulin Signaling WP481,0.7826884155231872,0.7837813035320988,0.19204256443032605,"['PTPN1', 'XBP1', 'SHC3', 'STX4', 'HRAS', 'PFKM', 'VAMP2']",0.9999194890104941,0,0,7
270,Amino Acid metabolism WP3925,0.7850459212244848,0.7191914801130189,0.17405373409001118,"['LDHA', 'PDHA1', 'GOT1']",0.9999194890104941,0,0,3
271,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7878204678809756,0.6873949579831933,0.16393341935739253,"['LATS1', 'BAX']",0.9999194890104941,0,0,2
272,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.7878204678809756,0.6873949579831933,0.16393341935739253,"['NDUFA13', 'COPS6']",0.9999194890104941,0,0,2
273,Hepatitis B infection WP4666,0.7919065823923381,0.7630948661876497,0.17803907163579571,"['YWHAQ', 'IRF3', 'BAD', 'CYCS', 'BAX', 'HRAS']",0.9999194890104941,0,0,6
274,Autophagy WP4923,0.7926639217322021,0.644647854477612,0.14978776678087263,['MAP1LC3B'],0.9999194890104941,0,0,1
275,Differentiation of white and brown adipocyte WP2895,0.7926639217322021,0.644647854477612,0.14978776678087263,['SMAD9'],0.9999194890104941,0,0,1
276,Pregnane X receptor pathway WP2876,0.7926639217322021,0.644647854477612,0.14978776678087263,['PSMC5'],0.9999194890104941,0,0,1
277,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7926639217322021,0.644647854477612,0.14978776678087263,['HRAS'],0.9999194890104941,0,0,1
278,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.7926639217322021,0.644647854477612,0.14978776678087263,['IRF3'],0.9999194890104941,0,0,1
279,Gastrin signaling pathway WP4659,0.7941514295850851,0.7466210714867285,0.17208205969499266,"['CCND1', 'BAD', 'RPS6', 'KIT', 'HRAS']",0.9999194890104941,0,0,5
280,Interferon type I signaling pathways WP585,0.8020277536586701,0.6651606879310864,0.14674247368951965,"['RPS6', 'RACK1']",0.9999194890104941,0,0,2
281,Ethanol effects on histone modifications WP3996,0.8110059117751877,0.6066725197541704,0.1270857202499556,['AHCY'],0.9999194890104941,0,0,1
282,RAS and bradykinin pathways in COVID-19 WP4969,0.8110059117751877,0.6066725197541704,0.1270857202499556,['NOS1'],0.9999194890104941,0,0,1
283,TLR4 Signaling and Tolerance WP3851,0.8110059117751877,0.6066725197541704,0.1270857202499556,['IRF3'],0.9999194890104941,0,0,1
284,Focal Adhesion WP306,0.8150873148331256,0.772062969924812,0.1578560231772905,"['SHC3', 'CCND1', 'BAD', 'VEGFB', 'RAC3', 'HRAS', 'MYL12B', 'PAK4', 'ACTG1']",0.9999194890104941,0,0,9
285,Phosphodiesterases in neuronal function WP4222,0.8153835882740295,0.6443160597572363,0.1315027274362115,"['ADCY2', 'NOS1']",0.9999194890104941,0,0,2
286,Mesodermal commitment pathway WP2857,0.8258869675249811,0.7269198963559181,0.13905785566152512,"['LATS1', 'EPB41L5', 'SETD2', 'CCND1', 'SESN1', 'RPL38']",0.9999194890104941,0,0,6
287,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8277266403865591,0.5729166666666666,0.10832268537706169,['DDIT3'],0.9999194890104941,0,0,1
288,One-carbon metabolism WP241,0.8277266403865591,0.5729166666666666,0.10832268537706169,['AHCY'],0.9999194890104941,0,0,1
289,Signaling of Hepatocyte Growth Factor Receptor WP313,0.8277266403865591,0.5729166666666666,0.10832268537706169,['HRAS'],0.9999194890104941,0,0,1
290,Trans-sulfuration and one-carbon metabolism WP2525,0.8277266403865591,0.5729166666666666,0.10832268537706169,['AHCY'],0.9999194890104941,0,0,1
291,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.839698186780585,0.6063052672049212,0.10592926248920238,"['IRF3', 'PIN1']",0.9999194890104941,0,0,2
292,TGF-beta Receptor Signaling WP560,0.839698186780585,0.6063052672049212,0.10592926248920238,"['SMAD9', 'HRAS']",0.9999194890104941,0,0,2
293,7-oxo-C and 7beta-HC pathways WP5064,0.8429692898785213,0.5427140612725845,0.09270899449326682,['THEM5'],0.9999194890104941,0,0,1
294,Fluoropyrimidine Activity WP1601,0.8429692898785213,0.5427140612725845,0.09270899449326682,['TDG'],0.9999194890104941,0,0,1
295,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.8429692898785213,0.5427140612725845,0.09270899449326682,['IRF3'],0.9999194890104941,0,0,1
296,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8429692898785213,0.5427140612725845,0.09270899449326682,['SUPT4H1'],0.9999194890104941,0,0,1
297,Lipid Metabolism Pathway WP3965,0.8429692898785213,0.5427140612725845,0.09270899449326682,['PDHA1'],0.9999194890104941,0,0,1
298,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.8429692898785213,0.5427140612725845,0.09270899449326682,['OMG'],0.9999194890104941,0,0,1
299,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.8429692898785213,0.5427140612725845,0.09270899449326682,['CCND1'],0.9999194890104941,0,0,1
300,Pathways affected in adenoid cystic carcinoma WP3651,0.8507345647530483,0.5889289048952915,0.09520336623821456,"['SETD2', 'HRAS']",0.9999194890104941,0,0,2
301,Melatonin metabolism and effects WP3298,0.856864408146737,0.5155317164179104,0.07963706593720758,['CALM2'],0.9999194890104941,0,0,1
302,Target Of Rapamycin (TOR) Signaling WP1471,0.856864408146737,0.5155317164179104,0.07963706593720758,['IDI1'],0.9999194890104941,0,0,1
303,The influence of laminopathies on Wnt signaling WP4844,0.856864408146737,0.5155317164179104,0.07963706593720758,['CCND1'],0.9999194890104941,0,0,1
304,Corticotropin-releasing hormone signaling pathway WP2355,0.8588080934312082,0.6181121495327103,0.09408271980027808,"['POMC', 'STAR', 'CRH']",0.9999194890104941,0,0,3
305,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8695310224231079,0.49093816631130066,0.06863377784659885,['HRAS'],0.9999194890104941,0,0,1
306,Prion disease pathway WP3995,0.8695310224231079,0.49093816631130066,0.06863377784659885,['HSP90B1'],0.9999194890104941,0,0,1
307,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.870754102627374,0.5569939687586747,0.07708554688926576,"['SMAD9', 'HRAS']",0.9999194890104941,0,0,2
308,3q29 copy number variation syndrome WP4906,0.8798098495833804,0.5422870902747063,0.06943957714248108,"['NCBP2', 'DYNLL1']",0.9999194890104941,0,0,2
309,Chemokine signaling pathway WP3929,0.8809894305327883,0.643316947565543,0.08151446542143848,"['GNG10', 'GNG3', 'SHC3', 'ADCY2', 'HRAS']",0.9999194890104941,0,0,5
310,Cell migration and invasion through p75NTR WP4561,0.8810776554730915,0.4685803934871099,0.05932673506421267,['NTRK2'],0.9999194890104941,0,0,1
311,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.8810776554730915,0.4685803934871099,0.05932673506421267,['CCND1'],0.9999194890104941,0,0,1
312,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8810776554730915,0.4685803934871099,0.05932673506421267,['NTRK2'],0.9999194890104941,0,0,1
313,Fragile X Syndrome  WP4549,0.8836815121263977,0.6146628876198986,0.07600832858951789,"['NTRK2', 'HOMER1', 'AP2S1', 'AP2M1']",0.9999194890104941,0,0,4
314,Endochondral Ossification with Skeletal Dysplasias WP4808,0.8882761022296175,0.5283344106873519,0.06259318214943296,"['HMGCS1', 'CALM2']",0.9999194890104941,0,0,2
315,Endochondral Ossification WP474,0.8882761022296175,0.5283344106873519,0.06259318214943296,"['HMGCS1', 'CALM2']",0.9999194890104941,0,0,2
316,Oncostatin M Signaling Pathway WP2374,0.8882761022296175,0.5283344106873519,0.06259318214943296,"['RPS6', 'HRAS']",0.9999194890104941,0,0,2
317,Disruption of postsynaptic signaling by CNV WP4875,0.8916032515129141,0.44816677482154443,0.051419980477733766,['HOMER1'],0.9999194890104941,0,0,1
318,Heart Development WP1591,0.8916032515129141,0.44816677482154443,0.051419980477733766,['VEGFB'],0.9999194890104941,0,0,1
319,ATM Signaling Pathway WP2516,0.9011980208854762,0.4294542910447761,0.04467624435317482,['GADD45A'],0.9999194890104941,0,0,1
320,G13 Signaling Pathway WP524,0.9011980208854762,0.4294542910447761,0.04467624435317482,['CALM2'],0.9999194890104941,0,0,1
321,Toll-like Receptor Signaling related to MyD88 WP3858,0.9011980208854762,0.4294542910447761,0.04467624435317482,['IRF3'],0.9999194890104941,0,0,1
322,Differentiation Pathway WP2848,0.9099442107575463,0.4122388059701493,0.03890379573689375,['KIT'],0.9999194890104941,0,0,1
323,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9099442107575463,0.4122388059701493,0.03890379573689375,['IRF3'],0.9999194890104941,0,0,1
324,Hedgehog Signaling Pathway WP4249,0.9099442107575463,0.4122388059701493,0.03890379573689375,['CCND1'],0.9999194890104941,0,0,1
325,IL-5 signaling pathway WP127,0.9099442107575463,0.4122388059701493,0.03890379573689375,['RPS6'],0.9999194890104941,0,0,1
326,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9123883296273886,0.7002613315054408,0.06420666702926264,"['GNG10', 'GNG3', 'RAB14', 'CAB39L', 'BAD', 'KIT', 'RPS6', 'VEGFB', 'ITGAE', 'NOS1', 'HRAS', 'HSP90B1']",0.9999194890104941,0,0,12
327,AGE/RAGE pathway WP2324,0.9168939333890049,0.47901331075065684,0.041560861991503134,"['CYCS', 'SOD1']",0.9999194890104941,0,0,2
328,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9168939333890049,0.47901331075065684,0.041560861991503134,"['IFI27L2', 'HRAS']",0.9999194890104941,0,0,2
329,Alpha 6 Beta 4 signaling pathway WP244,0.9179168069994242,0.396347588978186,0.03394658307453848,['HRAS'],0.9999194890104941,0,0,1
330,Neural Crest Cell Migration during Development WP4564,0.9179168069994242,0.396347588978186,0.03394658307453848,['PAK4'],0.9999194890104941,0,0,1
331,Regulation of Microtubule Cytoskeleton WP2038,0.9179168069994242,0.396347588978186,0.03394658307453848,['PARD6A'],0.9999194890104941,0,0,1
332,Endoderm differentiation WP2853,0.922649446778047,0.5561651455009734,0.044774583518617746,"['EPB41L5', 'SESN1', 'TCEAL2', 'NME1']",0.9999194890104941,0,0,4
333,Oxysterols derived from cholesterol WP4545,0.9251841748995538,0.38163349917081263,0.029676757153002102,['THEM5'],0.9999194890104941,0,0,1
334,Spinal Cord Injury WP2431,0.9313923043515258,0.5414307518093644,0.03848203416844198,"['CCND1', 'GADD45A', 'OMG', 'NOS1']",0.9999194890104941,0,0,4
335,Hepatitis C and Hepatocellular Carcinoma WP3646,0.9318086434427518,0.3679704157782516,0.025988942245777316,['CCND1'],0.9999194890104941,0,0,1
336,Prostaglandin Synthesis and Regulation WP98,0.9318086434427518,0.3679704157782516,0.025988942245777316,['S100A6'],0.9999194890104941,0,0,1
337,DNA IR-damage and cellular response via ATR WP4016,0.933671344612195,0.4476515243778671,0.03072267422970618,"['RPA2', 'EEF1E1']",0.9999194890104941,0,0,2
338,Microglia Pathogen Phagocytosis Pathway WP3937,0.9378470372526517,0.35524961399897065,0.02279580521572075,['RAC3'],0.9999194890104941,0,0,1
339,EGF/EGFR signaling pathway WP437,0.9414427527447323,0.5527364987314244,0.03335308045931961,"['NDUFA13', 'AP2S1', 'NEDD8', 'HRAS', 'AP2M1']",0.9999194890104941,0,0,5
340,Development of ureteric collection system WP5053,0.9433511628380882,0.3433768656716418,0.020024597646695737,['CCND1'],0.9999194890104941,0,0,1
341,Notch Signaling WP268,0.9433511628380882,0.3433768656716418,0.020024597646695737,['DLL3'],0.9999194890104941,0,0,1
342,Pre-implantation embryo WP3527,0.9433511628380882,0.3433768656716418,0.020024597646695737,['DDIT3'],0.9999194890104941,0,0,1
343,Vitamin D Receptor Pathway WP2877,0.9446844438466655,0.546806518447685,0.03111565808419692,"['CDKN2D', 'CCND1', 'GADD45A', 'S100A6', 'TNFRSF11B']",0.9999194890104941,0,0,5
344,Glioblastoma signaling pathways WP2261,0.9472054729414203,0.42012995674460263,0.022787528230879123,"['CCND1', 'HRAS']",0.9999194890104941,0,0,2
345,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9483682511200389,0.3322701011073664,0.017614436041547606,['IRF3'],0.9999194890104941,0,0,1
346,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9483682511200389,0.3322701011073664,0.017614436041547606,['TNFRSF11B'],0.9999194890104941,0,0,1
347,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9483682511200389,0.3322701011073664,0.017614436041547606,['RPS6'],0.9999194890104941,0,0,1
348,Wnt Signaling Pathway WP363,0.9483682511200389,0.3322701011073664,0.017614436041547606,['CCND1'],0.9999194890104941,0,0,1
349,Ectoderm Differentiation WP2858,0.9494699947662621,0.5077781242421093,0.026328981403813054,"['MAFB', 'KCNK10', 'TNFRSF11B', 'LY6E']",0.9999194890104941,0,0,4
350,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9529413611696173,0.3218575093283582,0.015514146053087695,['RPS6'],0.9999194890104941,0,0,1
351,Pathways Regulating Hippo Signaling WP4540,0.9534507682246074,0.4605663272422932,0.021954039863403246,"['LATS1', 'NTRK2', 'KIT']",0.9999194890104941,0,0,3
352,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9565288058095025,0.4537520615722925,0.020166726648307546,"['PTPN1', 'SHC3', 'HRAS']",0.9999194890104941,0,0,3
353,Vitamin B12 metabolism WP1533,0.9571097483659137,0.3120759837177748,0.013680541843583218,['SOD1'],0.9999194890104941,0,0,1
354,IL-4 signaling pathway WP395,0.9609092004432364,0.3028698419666374,0.012077043656313211,['BAD'],0.9999194890104941,0,0,1
355,Netrin-UNC5B signaling pathway WP4747,0.9609092004432364,0.3028698419666374,0.012077043656313211,['DAPK1'],0.9999194890104941,0,0,1
356,Cardiac Hypertrophic Response WP2795,0.9643723430021924,0.2941897654584222,0.010672560714887624,['CALM2'],0.9999194890104941,0,0,1
357,NRF2 pathway WP2884,0.9674995314709102,0.467089038183519,0.015432779859342815,"['FTH1', 'TXN', 'SLC6A20', 'FTL']",0.9999194890104941,0,0,4
358,Peptide GPCRs WP24,0.9704060437073627,0.2782371924162969,0.008358438165874936,['HCRTR1'],0.9999194890104941,0,0,1
359,Adipogenesis WP236,0.9732847399938099,0.41114018691588783,0.011133099965697264,"['GADD45A', 'DDIT3', 'GTF3A']",0.9999194890104941,0,0,3
360,Ebola Virus Pathway on Host WP4217,0.9732847399938099,0.41114018691588783,0.011133099965697264,"['IRF3', 'EIF2S1', 'ACTG1']",0.9999194890104941,0,0,3
361,PI3K-Akt signaling pathway WP4172,0.9760009048557672,0.5839017202853156,0.01418400364270391,"['NTRK2', 'GNG10', 'GNG3', 'CCND1', 'BAD', 'KIT', 'RPS6', 'VEGFB', 'COL9A3', 'HRAS', 'HSP90B1']",0.9999194890104941,0,0,11
362,B Cell Receptor Signaling Pathway WP23,0.9775764622761619,0.3427637721755369,0.007773460035210966,"['PIP5K1A', 'HRAS']",0.9999194890104941,0,0,2
363,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9775971641290321,0.2572994402985075,0.005829785590626562,['YWHAQ'],0.9999194890104941,0,0,1
364,RANKL/RANK signaling pathway WP2018,0.9795827702442612,0.2510010921004732,0.005177786726366612,['TNFRSF11B'],0.9999194890104941,0,0,1
365,Genes related to primary cilium development (based on CRISPR) WP4536,0.9808633355032528,0.33164663714948345,0.006408122931000946,"['TRAF3IP1', 'DYNLL1']",0.9999194890104941,0,0,2
366,MECP2 and Associated Rett Syndrome WP3584,0.9813925175245136,0.24500266524520256,0.004601831073157168,['RPS6'],0.9999194890104941,0,0,1
367,Metapathway biotransformation Phase I and II WP702,0.9859715519954724,0.3667890520694259,0.005181913833653477,"['AKR7A3', 'GPX4', 'GSTO1']",0.9999194890104941,0,0,3
368,Wnt signaling WP428,0.986093216164327,0.3114336643748408,0.0043614382233666165,"['CCND1', 'PRICKLE2']",0.9999194890104941,0,0,2
369,Osteoblast differentiation WP4787,0.987165533491788,0.30675752888219965,0.003962552600626042,"['SMAD9', 'DLL3']",0.9999194890104941,0,0,2
370,ESC Pluripotency Pathways WP3931,0.9881571263170119,0.30221892678640083,0.0036005030590487625,"['SMAD9', 'HRAS']",0.9999194890104941,0,0,2
371,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9887272558845905,0.35404447309055753,0.004013718305141431,"['STRAP', 'HRAS', 'DLL3']",0.9999194890104941,0,0,3
372,Male infertility WP4673,0.9899212390240437,0.293530745631586,0.00297343579679736,"['PEX10', 'NOS1']",0.9999194890104941,0,0,2
373,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9902849801092516,0.20986902223575998,0.0020488502290800874,['ACTG1'],0.9999194890104941,0,0,1
374,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9911465475205565,0.20565298507462687,0.001828846733586907,['CCND1'],0.9999194890104941,0,0,1
375,Neural Crest Differentiation WP2064,0.9911465475205565,0.20565298507462687,0.001828846733586907,['DLL3'],0.9999194890104941,0,0,1
376,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9919317510060031,0.20160228270412642,0.0016331747402827076,['CALM2'],0.9999194890104941,0,0,1
377,T-cell receptor (TCR) signaling pathway WP69,0.9919317510060031,0.20160228270412642,0.0016331747402827076,['HRAS'],0.9999194890104941,0,0,1
378,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9938938643646196,0.19035033167495855,0.0011658680512150299,['CCND1'],0.9999194890104941,0,0,1
379,Toll-like Receptor Signaling Pathway WP75,0.994435513744174,0.18687245590230664,0.0010427531032366042,['IRF3'],0.9999194890104941,0,0,1
380,Nuclear Receptors Meta-Pathway WP2882,0.9955686794708242,0.4495073002115256,0.001996337406940976,"['PSMC5', 'CCND1', 'FTH1', 'AIP', 'BAX', 'TXN', 'SLC6A20', 'FTL']",0.9999194890104941,0,0,8
381,Wnt signaling pathway and pluripotency WP399,0.9957889329319822,0.17715838908903758,0.0007476010643321171,['CCND1'],0.9999194890104941,0,0,1
382,Regulation of toll-like receptor signaling pathway WP1449,0.9962162217183307,0.25030174671494615,0.0009488826280651293,"['CUEDC2', 'IRF3']",0.9999194890104941,0,0,2
383,MAPK Signaling Pathway WP382,0.996615310024151,0.39609396257218005,0.0013429292484333443,"['NTRK2', 'RRAS', 'GADD45A', 'DDIT3', 'RAC3', 'HRAS']",0.9999194890104941,0,0,6
384,"GPCRs, Class A Rhodopsin-like WP455",0.9991483059929324,0.2537730748435931,0.00021622910059028487,"['GPR22', 'OR6A2', 'HCRTR1']",0.9999194890104941,0,0,3
385,Ciliopathies WP4803,0.9999194890104941,0.1596784547152194,1.2856387939097435e-05,"['TRAF3IP1', 'CCDC28B']",0.9999194890104941,0,0,2
